(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -8.65%7.95B | -5.57%5.37B | 0.44%2.89B | 0.43%12.22B | 0.60%8.7B | -1.68%5.69B | -0.30%2.88B | -1.46%12.17B | -0.43%8.65B | -4.96%5.79B |
Operating income | -8.65%7.95B | -5.57%5.37B | 0.44%2.89B | 0.43%12.22B | 0.60%8.7B | -1.68%5.69B | -0.30%2.88B | -1.46%12.17B | -0.43%8.65B | -4.96%5.79B |
Operating expenses | 0.90%-6.08B | -2.27%-4.14B | -3.52%-2.08B | 1.78%-8.83B | 3.59%-6.13B | 4.69%-4.04B | 1.18%-2.01B | -5.54%-8.99B | -7.53%-6.36B | -4.55%-4.24B |
Gross profit | -27.12%1.87B | -24.85%1.24B | -6.73%806.74M | 6.69%3.39B | 12.22%2.57B | 6.57%1.65B | 1.81%864.9M | -17.02%3.18B | -17.40%2.29B | -23.96%1.55B |
Selling expenses | -9.39%-1.26M | ---705.36K | ---- | ---1.79M | ---1.15M | ---- | ---- | ---- | ---- | ---- |
Administrative expenses | -0.34%-523.4M | 2.85%-356.16M | -7.69%-169.6M | 9.69%-735.74M | -0.73%-521.62M | -3.77%-366.62M | -3.40%-157.48M | -1.92%-814.67M | 1.22%-517.85M | 5.12%-353.3M |
Research and development expenses | 42.34%-16.02M | 56.04%-8.76M | 59.71%-4.08M | 26.04%-39.29M | -585.27%-27.79M | -1,036.49%-19.92M | -896.00%-10.12M | -470.84%-53.13M | 12.49%-4.06M | 44.22%-1.75M |
Profit from asset sales | 98,529.34%14M | --46.56K | --43.61K | -96.15%194.69K | -99.70%14.2K | ---- | ---- | -96.51%5.05M | -86.64%4.67M | -87.02%4.64M |
Impairment and provision | 203.39%85.89M | 116.61%13.46M | 115.43%812.52K | -84.03%-310.98M | -226.79%-83.08M | -212.53%-81.02M | -874.27%-5.27M | 3.10%-168.98M | 37.17%-25.42M | 36.77%-25.93M |
-Other impairment is provision | 203.39%85.89M | 116.61%13.46M | 115.43%812.52K | -84.03%-310.98M | -226.79%-83.08M | -212.53%-81.02M | -874.27%-5.27M | 3.10%-168.98M | 37.17%-25.42M | 36.77%-25.93M |
Special items of operating profit | 130.89%333.38M | 26.72%109.31M | 28.02%57.68M | -21.20%281.61M | -47.39%144.39M | -44.17%86.26M | -50.06%45.06M | -32.58%357.39M | -21.87%274.46M | -24.68%154.5M |
Operating profit | -15.35%1.68B | -22.14%933.43M | -4.40%662.16M | 2.62%2.44B | 2.45%1.98B | -5.18%1.2B | -8.84%692.62M | -29.96%2.38B | -22.85%1.93B | -29.55%1.26B |
Financing cost | 20.72%-266.79M | 20.12%-183.67M | 16.59%-95.55M | 7.19%-432.16M | 1.84%-336.51M | -0.79%-229.93M | -3.82%-114.56M | 11.54%-465.64M | 20.03%-342.83M | 22.66%-228.12M |
Special items of earning before tax | -47.85%4.16M | -42.72%3.74M | -46.30%722.94K | -1.49%29.64M | -74.02%7.98M | -81.94%6.52M | -95.98%1.35M | 114.28%30.09M | 224.07%30.72M | 267.24%36.11M |
Earning before tax | -14.41%1.41B | -22.75%753.5M | -2.08%567.33M | 4.91%2.03B | 1.90%1.65B | -9.03%975.42M | -15.16%579.4M | -26.92%1.94B | -21.01%1.62B | -27.46%1.07B |
Tax | 25.08%-320.36M | 16.84%-211.29M | 0.20%-149.39M | -12.97%-527.74M | -11.56%-427.6M | 2.48%-254.06M | 13.09%-149.69M | 18.93%-467.17M | 25.39%-383.3M | 21.95%-260.54M |
After-tax profit from continuing operations | -10.68%1.09B | -24.83%542.21M | -2.74%417.94M | 2.35%1.51B | -1.08%1.22B | -11.13%721.35M | -15.85%429.71M | -29.14%1.47B | -19.55%1.24B | -29.06%811.73M |
Earning after tax | -10.68%1.09B | -24.83%542.21M | -2.74%417.94M | 2.35%1.51B | -1.08%1.22B | -11.13%721.35M | -15.85%429.71M | -29.14%1.47B | -19.55%1.24B | -29.06%811.73M |
Minority profit | -4.27%148.36M | -3.00%88.77M | 15.18%46.02M | 5.92%164.14M | 36.11%154.98M | 31.19%91.52M | 38.49%39.96M | -4.41%154.96M | -9.75%113.86M | -17.82%69.76M |
Profit attributable to shareholders | -11.61%945.51M | -28.01%453.44M | -4.58%371.92M | 1.93%1.34B | -4.85%1.07B | -15.11%629.83M | -19.11%389.75M | -31.23%1.32B | -20.43%1.12B | -29.96%741.96M |
Basic earnings per share | 0.00%0.04 | -33.33%0.02 | 0.00%0.02 | 20.00%0.06 | -20.00%0.04 | 0.00%0.03 | 0.00%0.02 | -37.50%0.05 | -16.67%0.05 | -40.00%0.03 |
Diluted earnings per share | 0.00%0.04 | -33.33%0.02 | 0.00%0.02 | 20.00%0.06 | -20.00%0.04 | 0.00%0.03 | 0.00%0.02 | -37.50%0.05 | -16.67%0.05 | -40.00%0.03 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data